Prevention of manifest metastasis with monoclonal antibodies: A novel approach to immunotherapy of solid tumours

Schneider-Gädicke, E.; Riethmüller, Gert

doi:10.1016/0959-8049(95)00279-r

Search citation statements

Order By: Relevance

Paper Sections

Select...

Adjuvant Chemotherapy1

Immunotherapy1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1998

2000

Publication Types

Select...

Article4

Book2

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 12 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These modi®cations may have signi®cant bene®ts in terms of quality of life compared with standard regimens. There are a number of newer agents, currently being assessed as adjuvant treatments for primary colonic cancer, that could be evaluated as adjuvant treatments following resection of metastatic liver lesions 62,63 .…”

Section: Adjuvant Chemotherapymentioning

confidence: 99%

See 1 more Smart Citation

Treatment of colorectal liver metastases

Geoghegan

Scheele

1999

British Journal of Surgery

219

132

View full text Add to dashboard Cite

show abstract

Section: Adjuvant Chemotherapymentioning

confidence: 99%

“…Clinical trials have shown that the monoclonal antibody 17-1A is effective in increasing survival following resection of Dukes C primary colorectal tumours 62,68 . Further studies of this and other monoclonal antibodies in patients with colonic cancer are continuing.…”

Section: Immunotherapymentioning

confidence: 99%